Webcasts - BioPharm International

ADVERTISEMENT

Webcasts
LIVE WEBCASTS

Preparing for the New Elemental Impurities Guidelines
Tuesday October 14, 2014 at 11AM for North America; Tuesday, October 21, 2014 at 15:00 CEST for Europe

With the long anticipated revised guidelines for elemental impurities on the horizon, bio/pharmaceutical companies should initiate plans to transition to these new guidelines. In this webcast, experts (API, excipients and analytical testing) will discuss risk assessment, proposed test methods, and sample preparation techniques.

Register free www.pharmtech.com/elemental
Sponsored by SGS Life Science Services


The Benefits of High Performing Chromatography Resins; Including POROS® XQ, A New Strong Anion Exchange

Wednesday, October 29, 2014 at 9AM EDT and 2PM EDT

Learn how high capacity, high resolution and salt tolerant ion-exchange (IEX) resins can help revolutionize your approach to bioprocess chromatography. An expert will demonstrate the benefits of the newest AEX resin to downstream purification processes, including increased process flexibility and productivity, and improved cost of goods.

Register free www.pharmtech.com/POROSXQ
Sponsored by Life Tech


ON-DEMAND WEBCASTS


Accelerating Vaccine Development: Regulatory, Biosafety, and Clinical Strategies
Available until September 9, 2015

The drive to bring efficacious, more cost-effective vaccines to market is challenging vaccine makers to innovate throughout the development continuum. This webcast will provide companies developing seasonal and pandemic influenza vaccines, as well as universal vaccines, with vital regulatory, biosafety, and clinical testing strategies to accelerate development.

Register free at www.biopharminternational.com/vaccinedev
Sponsored by SGS Life Science Services


Glycan Profiling and Differential Analysis to Elucidate Functional Differences in Therapeutic Antibodies
Available until July 31, 2015

In this free webcast, experts from Agilent and Gilead Science will discuss the challenges of characterization of glycan profiles throughout various phases of therapeutic mAbs development.

Audience members will learn about rapid glycopeptide and glycan analysis of monoclonal antibodies using LC, LC/MS and HILIC, and a microfluidic-based HPLC-Chip coupled to an Agilent Accurate-Mass Q-TOF LC/MS. The discussion will include differential analysis using MassHunter Molecular Feature Extractor and other software tools to elucidate functional differences in the studied antibodies.

Register free at www.biopharminternational.com/analysis
Sponsored by Agilent Technologies


Fast, Robust LC and LCMS Workflows for the Comprehensive Characterization of Bio-Therapeutic Proteins
Available until June 3, 2015

Would you like to reduce method development time for mAb characterization from weeks to minutes? Have finalized methods that are more robust than previous methods? The webinar will describe new technology and workflows for mAb characterization with advice on simplified method develop`ment..

Register free at www.biopharminternational.com/fast
Sponsored by Thermo Fisher Scientific


Delivering Biologics with a Difference
Available until June 5, 2015

As the biologics market continues to grow with additional launches, expanding indications, and approvals of biosimilars, the delivery platform will play a more critical role in product differentiation. Join us for this webinar to explore the advantages, challenges, case studies and science behind delivering biologics with a difference.

Register free at www.pharmtech.com/difference
Sponsored by Baxter BioPharma Solutions


MAb manufacturing:  where are we headed, cost or capabilities?
Available until May 27, 2015

MAb manufacturing,  where are we heading?  Join the discussion with Gunter Jagschies of GE Healthcare Life Sciences.

Register free at www.biopharminternational.com/MAb
Sponsored by GE Healthcare


Effective Viral Contamination Testing Programs for Biologics Product Manufacturing
Available until May 20, 2015

Biopharmaceutical manufacturers need comprehensive virus testing programs to ensure product safety throughout various manufacturing stages. Learn how to establish or improve practices for effective virus testing programs and review test methods for virus detection and quantitation throughout the biopharmaceutical manufacturing process.

Register free at www.biopharminternational.com/virustesting
Sponsored by SGS Life Science Services


Best Practices for Effective Environmental Monitoring Program in Bio/Pharmaceutical Production
Available until April 22, 2015

Contamination poses a threat to process and product integrity, as well as patient safety. A comprehensive environmental monitoring program can ensure that manufacturing areas, cleanrooms, production equipment, and water and gas utilities are free of viable and non-viable contamination and meet regulatory requirements. In this webcast, learn about pertinent regulatory and quality standards, as well as best practices for establishing and maintaining an effective environmental monitoring program. Review measures for testing pharmaceutical water systems according to U.S. Pharmacopeial Convention (USP) water monograph as well as procedures to evaluate the purity of production gases.

Register free at www.pharmtech.com/emp
Sponsored by SGS Life Science Services


Increase Control over Quality Management Through Strong Supplier Relationships
Available until April 2, 2015

Understand the regulatory obligations of bio/pharmaceutical companies in a global, outsourced supply chain and challenges with building effective supplier relationships. Learn how a supplier quality management system should provide the ability to aggregate quality metrics in a consistent, measurable, normalized, and repeatable way.

Register free at www.pharmtech.com/relationships
Sponsored by Sparta Systems


Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities
Available until April 1, 2015

Tracking the clearance of host cell components and process additives residuals is an essential part of process development and characterization of biopharmaceuticals.
In this webinar, learn about challenges presented by residuals, regulatory expectations, analytical approaches for cell- and process-associated residuals, a platform method technology for residuals, and matrix effects.

Register free at www.pharmtech.com/navigating
Sponsored by Eurofins Lancaster Laboratories


Identifying, Analyzing, and Controlling Particles throughout the Biopharmaceutical Product Lifecycle
Available until March 25, 2015

Preformulation screening can identify potential problems and form the basis for long-term stability of biopharmaceutical drug products. One of the main challenges in the development of stable biopharmaceutical products is the control of aggregation and particulate formation. Review how particles can potentially develop through the life cycle of a drug, understand regulatory expectations, and assess analytical techniques available to assess protein aggregation and particulates for innovator drugs and biosimilars.

Register free at www.biopharminternational.com/particles
Sponsored by SGS Life Science Services


Streamlining Recombinant Protein Manufacturing
Available until December 12, 2014

Review the common challenges with recombinant protein production from E. coli, which include protein aggregation, lengthy purification and inefficient refolding processes. A system that requires fewer purification steps and no refolding, with the goals of reducing the number of potential difficulties, lowering costs, and speeding time to market will be discussed.

Register free at: www.biopharminternational.com/streamlining

Sponsor: Ajinomoto Althea


Advancing High Resolution Biopharmaceutical Analytics: Why intact mass, peptide mapping, and glycan analysis should be routine and automated across your organization
Available until December 3, 2014

This webinar will focus on advantages of using the Waters Biopharmaceutical Platform Solution with UNIFI Software to assess, monitor, and compare the critical quality attributes of innovator and biosimilar biopharmaceuticals. The speakers will look beyond the high-resolution UPLC/QTof MS data gained during an analysis, to how informatics can facilitate a better understanding of the similarities and differences between an innovator and a biosimilar product.

Register Free at www.biopharminternational.com/highres

Sponsor: Waters


 

 

For more multimedia content from Biopharm International, including podcasts and videos, click here.

ADVERTISEMENT

ADVERTISEMENT

Click here